Opaleye Management, 10% Owner: Eton Pharmaceuticals ETON Buy · Filed 24/09/12

Trade details

Type: Insider buy
Amount: $232,500
Shares · price: 50,000 sh · $4.65 a share
Held after: 2,660,000 sh
Stock: Eton Pharmaceuticals ETON
Person: Opaleye Management10% Owner
Trade date: 24/09/10
Filed: 24/09/12
Days to filing: 2 days

First buy since 2023

Insiders buying this week: 1 insiders
Holding change: +1.9%

Eton Pharmaceuticals trades, last 26 weeks

What else happened in Eton Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 24/08/11~24/10/10

Opaleye Management's recent trades

Opaleye Management10% Owner
BuyGrace Therapeutics
Buy
Grace Therapeutics
GRCE
$20.5K
9,771 sh
$20.5K
Filed 10/01
Traded 09/21
Opaleye Management10% Owner
BuyGrace Therapeutics
Buy
Grace Therapeutics
GRCE
$11.2K
5,318 sh
$11.2K
Filed 10/01
Traded 09/23
Opaleye Management10% Owner
BuyAlpha Cognition
Buy
Alpha Cognition
ACOG
$157.1K
18,337 sh
$157.1K
Filed 09/28
Traded 09/24
Opaleye Management10% Owner
BuyAlpha Cognition
Buy
Alpha Cognition
ACOG
$113.7K
13,426 sh
$113.7K
Filed 09/28
Traded 09/25
Opaleye Management10% Owner
BuyAlpha Cognition
Buy
Alpha Cognition
ACOG
$975K
152,336 sh
$975K
Filed 06/29
Traded 06/26